Scientists discover a genetic mechanism for cancer progression

September 11, 2015 by Jeannette Spalding
Cancer — Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0

Genetics researchers from Case Western Reserve School of Medicine have identified a novel long non-coding RNA (lncRNA), dubbed DACOR1, that has the potential to stymie the growth of tumor cells in the second-most deadly form of cancer in the U.S.—colorectal cancer.

The researchers found that this lncRNA is present in cells of healthy colons, but becomes suppressed in those carrying the disease. More importantly, this lncRNA interacts with a key enzyme known as DNMT1 that has important functions in all healthy cells of the body. Thus, the authors applied a name to this novel lncRNA—DACOR1, which stands for DNMT1-Associated Colon Cancer Repressed lncRNA-1.

The scientists' next challenge is to determine how to deliver DACOR1 to tumors where it may be able to slow, or even stop, the spread of malignant cells. The researchers' initial findings appeared in this month's edition of Human Molecular Genetics.

"We found that the metabolism of cells slows when we put DACOR1 back in," said senior author Ahmad M. Khalil, PhD, an assistant professor of genetics and genome sciences. "If we could figure out a way to deliver DACOR1 to tumors, we could change the methylation patterns in cancer cells to either destroy or at least regress tumors."

DNA methylation affects the molecule's function, including gene expression. Whenever a biological process affects genetic expression, the potential exists to promote health or cause disease. To understand what factors decide which outcomes in humans, scientists first identify how different molecules are supposed to act—and, in turn, the elements that make their functions go awry.

Khalil, a member of the Case Comprehensive Cancer Center, began the journey to the team's discovery with a hypothesis—namely, that lncRNA molecules directly regulate the enzyme DNMT1 that adds methylation to DNA. This ongoing chemical modification of our DNA—a process known as DNA methylation—can help prevent cancer by maintaining a healthy level of gene expression, which in turn controls the extent of cell growth in the body.

During their research, investigators found that specific lncRNAs regulate DNA methylation in specific human genes. Researchers also sought clues on how lncRNAs affect normal tissue versus cancerous tissue and characterized one particular lncRNA, DACOR1, which is present in healthy colon tissue but missing from colon cancer tissue.

"Cancer cells do not want certain lncRNAs around because they instruct normal cells to grow at a specific rate," said Khalil, the study's senior author. "Our research, in part, explains how cancer cells change their DNA methylation pattern, and this change is a major mechanism where normal cells become cancer cells."

Methylation is a process where a methyl group is added into critical points along our DNA. In cancer, many regions of the DNA are not methylated, leading to untimely gene expression, and unwanted cell reproduction. In some instances, genes that trigger cancer, known as oncogenes, spring into action.

DNA methylation occurs through enzymes known as DNA methyltransferases (DNMTs), and there are only three of them in the human genome: DNMT1, DNMT3A and DNMT3B. DNMT1 is the most important one because of its activity in all cell types, so investigators focused on how a subset of lncRNAs might interact with DNMT1. Khalil's hypothesis was that a subset of lncRNAs interacts with DNMT1 and that cancer cells alter the expression of these specific lncRNAs to change the location of where the DNMT1 enzyme triggers methylation along the DNA.

In their research, Khalil's team first isolated 148 lncRNAs from 8,300 known lncRNAs. These 148 lncRNAs are associated with DNMT1 in . To test their hypothesis in depth, the researchers focused their study on a key lncRNA that becomes suppressed in colon cancer—DACOR1.

Then investigators obtained normal and cancerous colon tissue from public datasets and compared how DACOR1 acted within each. They found that DACOR1 is active in normal colon tissue but repressed in colon cancer tissue. Similar results were found in studying 21 colon cancer cell lines from the Markowitz Laboratory of Genetic Colon Cancer Research at Case Western Reserve—DACOR1 is suppressed in colon cancer.

Investigators also pondered whether returning DACOR1, and therefore, DNA methylation, to would slow their growth. The answer was yes. In two colon cancer cell lines, the DNA methylation pattern changed when the lncRNA DACOR1 was injected into the cells. Additionally, investigators placed DACOR1 into cancer cells to track where this specific lncRNA went. DACOR1 returned to those cancer-suppressing regions of the DNA where it had been missing in the cancer cells.

"These experiments showed us that DNMT1-associated lncRNAs are regulating DNA methylation and subsequent gene expression, which controls cell growth," Khalil said.

Next steps for Khalil's team will be more research into DACOR1 and the effects of other lncRNAs believed to suppress colon cancer. Perhaps defects in a number of lncRNAs work in synergistic unison to drive the onset of colon cancer. Eventually, the potential is there to develop a therapy that would reactivate key lncRNAs in their job of maintaining normal, controlled cell growth and prevent unbridled leading to cancer. If nothing else, the lack of colon cancer-repressing genes could serve as an early-detection biomarker for .

"Clearly, have a way of changing in a way that is advantageous to them, but how they do that, we don't entirely understand yet," Khalil said. "We do know now that cancer changes the expression of key cancer-suppressing lncRNAs in a way that is advantageous to cancer cell proliferation."

Explore further: Researchers identify new stem cell population important in the growth of colon cancer

Related Stories

Researchers identify new stem cell population important in the growth of colon cancer

June 16, 2015
Researchers at Lawson Health Research Institute have identified a new stem cell population in the colon linked to cancer growth. The findings, which were recently published in the prominent journal Cell Stem Cell, will significantly ...

Long non-coding RNA modulates colorectal cancer metabolism

April 20, 2015
Long non-coding RNAs (lncRNA) are unusual in that they don't encode proteins like normal RNA. Yet they do play a role in regulating cellular functions and interest cancer researchers.

Researchers identify efficient methylating enzyme for cancer development

January 23, 2015
A recent study may help begin to explain how cancer develops though the abnormal turning on and off of genes. Researchers have discovered that the increase of methyl tags in cancer cells is due to highly efficient DNA methyl ...

Study reveals new insight into DNA repair

August 3, 2015
DNA double-strand breaks (DSBs) are the worst possible form of genetic malfunction that can cause cancer and resistance to therapy. New information published this week reveals more about why this occurs and how these breaks ...

Noncoding RNA CCDC26 regulates KIT expression

June 2, 2015
A long, noncoding RNA (lncRNA), which might have impact on tyrosine kinase-targeted leukemia therapy, was found to be expressed in a leukemia cell line. The function of the lncRNA CCDC26 is not fully understood; however, ...

Recommended for you

An architect gene is involved in the assimilation of breast milk

October 17, 2017
A family of "architect" genes called Hox coordinates the formation of organs and limbs during embryonic life. Geneticists from the University of Geneva (UNIGE) and the Swiss Federal Institute of Technology in Lausanne (EPFL), ...

Study identifies genes responsible for diversity of human skin colors

October 12, 2017
Human populations feature a broad palette of skin tones. But until now, few genes have been shown to contribute to normal variation in skin color, and these had primarily been discovered through studies of European populations.

Genes critical for hearing identified

October 12, 2017
Fifty-two previously unidentified genes that are critical for hearing have been found by testing over 3,000 mouse genes. The newly discovered genes will provide insights into the causes of hearing loss in humans, say scientists ...

Team completes atlas of human DNA differences that influence gene expression

October 11, 2017
Researchers funded by the National Institutes of Health (NIH) have completed a detailed atlas documenting the stretches of human DNA that influence gene expression - a key way in which a person's genome gives rise to an observable ...

Genetic advance for male birth control

October 10, 2017
When it comes to birth control, many males turn to two options: condoms or vasectomies. While the two choices are effective, both methods merely focus on blocking the transportation of sperm.

Researchers uncover new congenital heart disease genes

October 9, 2017
Approximately one in every 100 babies is born with congenital heart disease (CHD), and CHD remains the leading cause of mortality from birth defects. Although advancements in surgery and care have improved rates of survival ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.